Hunter Biden, President Joe Biden’s youngest son, has been subject to a federal investigation since 2018 for his foreign business practices. After pleading not guilty to two misdemeanor tax charges last month, Devon Archer, Biden’s former business partner, told congressional investigators that Hunter would tout the Biden ‘brand’ and often have then-Vice President Biden speak on business phone calls. However, Archer’s testimony contradicts that of the White House, which claims the President was never involved in any of his son’s business deals. On the Rundown, FOX News Sunday Anchor, Shannon Bream, talks about how Hunter Biden was able to sell his family’s name and status, what former President Trump’s third indictment means for the 2024 election, and why many Americans are losing confidence in President Biden.
Two decades of research and experimentation may have created a “cancer-killing pill” that some medical experts see as potentially the biggest game changer for the future of cancer treatments. Linda Malkas is a professor of molecular diagnostics and experimental therapeutics and has been working on this drug at the cancer treatment and research facility, City of Hope. She has named the drug, AOH1996, after 9-year-old cancer patient Anna Oliva Healey, who died in 2005. Healey’s parents asked Malkas if there was anything she could find a cure for their daughter’s cancer, and since then she has worked tirelessly in Anna’s honor to save others like her. Linda Malkas Ph.D. joins the podcast to discuss how the drug works to target certain proteins to exclusively eliminate cancerous cells, how Anna served as her inspiration for the drug’s development, and the bright future of this cancer treatment.
Don’t miss the good news with Tonya J. Powers.
Plus, commentary from host of OutKick’s Tomi Lahren is Fearless, Tomi Lahren.
